Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Young Jin Yuh"'
Autor:
Jung Sun Kim, Tae Min Kim, Myoung Joo Kang, Sung Ae Koh, Hyunkyung Park, Seung-Hyun Nam, Jae Joon Han, Gyeong-Won Lee, Young Jin Yuh, Hee Jeong Lee, Jung Hye Choi
Publikováno v:
The Korean Journal of Internal Medicine, Vol 38, Iss 5, Pp 747-757 (2023)
Background/Aims Little attention is paid to chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) in Korea due to the rarity of the disease. With its rising incidence, we aimed to evaluate recent changes in treatment patterns and survival
Externí odkaz:
https://doaj.org/article/1e6ad20e90a24fc19658f4ed258c3970
Autor:
Ja Min Byun, Ho Young Kim, Seung-Hyun Nam, Ho-Jin Shin, Seulki Song, Jinny Park, Sang Hoon Han, Yong Park, Young Jin Yuh, Yeung-Chul Mun, Young Rok Do, Sang Kyun Sohn, Sung Hwa Bae, Dong-Yeop Shin, Sung-Soo Yoon
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
As the discussion of first-line anagrelide treatment is ongoing, we aimed to prospectively examine the efficacy and safety of anagrelide in cytoreduction therapy-naïve high risk essential thrombocythemia (ET) patients in Korea. Seventy patients from
Externí odkaz:
https://doaj.org/article/053c6a7d2e1f40f3947f13cdf422dbf4
Autor:
Eun Hee Jung, Junshik Hong, Sung-Yong Kim, Young Park, Young Jin Yuh, Yeung-Chul Mun, Won-Sik Lee, Sung-Kyu Park, Soo Mee Bang
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e931-e937
Ruxolitinib is an established treatment for myelofibrosis (MF) that has demonstrated clinical benefit by reducing spleen size and debilitating MF-related symptoms. However, despite the efficacy of ruxolitinib, anemia remains a major adverse event tha
Autor:
Seo-Yeon Ahn, Sang Kyun Son, Gyu Hyung Lee, Inho Kim, June-Won Cheong, Won Sik Lee, Byung Soo Kim, Deog-Yeon Jo, Chul Won Jung, Chu Myoung Seong, Jae Hoon Lee, Young Jin Yuh, Min Kyoung Kim, Hun-Mo Ryoo, Moo-Rim Park, Su-Hee Cho, Hoon-Gu Kim, Dae Young Zang, Jinny Park, Hawk Kim, Seryeon Lee, Sung-Hyun Kim, Myung Hee Chang, Ho Sup Lee, Chul Won Choi, Jihyun Kwon, Sung-Nam Lim, Suk-Joong Oh, Inkyung Joo, Dong-Wook Kim
Publikováno v:
Blood Research. 57:144-151
Nilotinib is a tyrosine kinase inhibitor approved by the Ministry of Food and Drug Safety for frontline and 2nd line treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). This study aimed to confirm the safety and efficacy
Autor:
Ja Min Byun, Ho Young Kim, Seung-Hyun Nam, Ho-Jin Shin, Seulki Song, Jinny Park, Sang Hoon Han, Yong Park, Young Jin Yuh, Yeung-Chul Mun, Young Rok Do, Sang Kyun Sohn, Sung Hwa Bae, Dong-Yeop Shin, Sung-Soo Yoon
Publikováno v:
Frontiers in Oncology; 11/23/2022, Vol. 12, p01-09, 9p
Publikováno v:
Journal of Pharmacological Sciences, Vol 94, Iss 3, Pp 325-328 (2004)
Inflammation is a significant component of chronic neurodegenerative diseases. Cyclooxygenase-2 (COX-2) is expressed in activated microglial cells and appears to be an important source of prostaglandins during inflammatory conditions. To investigate
Externí odkaz:
https://doaj.org/article/7eb5925a37b44d30a44ade3acd5a734a
Autor:
Der Sheng Sun, Young Jin Yuh, Hyeok Shim, Jong Youl Jin, Sung Ae Koh, Jung Hye Choi, Byeong Bae Park, Seok-Hyun Kim, Hyo Jung Kim, Soon Il Lee, Jae Joon Han, Yeung-Chul Mun, Hye Jin Kang, Yun Hwa Jung, Seung Hyun Nam, Tae Min Kim, Jun Ho Yi, Jung Hye Kwon, So Young Chong
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The treatment strategy for elderly patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) has not been established because of poor treatment tolerability and lack of data. Materials and methods This multicenter retrospective
Autor:
Tae Hee Han, Young Jin Yuh, Hyun Ho Oh, Moon Hyang Park, Byeong Seok Sohn, Soo Ya Bae, Seong Jin Choi
Publikováno v:
The Korean Journal of Medicine. 90:258-261
Autor:
Sul Hee Kim, Sung Rok Kim, Wook Hyun Yeo, Young Jin Yuh, Byeong Seok Sohn, Young Geun Jee, Hyun Jung Kim
Publikováno v:
The Korean Journal of Medicine. 90:55-58
55 Copyrightc 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrest
Autor:
BYEONG SEOK SOHN1, YOUNG JIN YUH1, HONG SUK SONG2, BONG-SEOG KIM3, KYUNG HEE LEE4, JOUNG-SOON JANG5, SUNG ROK KIM1 srkjoy@naver.com
Publikováno v:
Oncology Letters. Aug2015, Vol. 10 Issue 2, p1204-1210. 7p.